Test Repertoire (Cytology)

on .

 

All unfixed Cytology cell samples will begin to degenerate from the moment of collection, thereby rendering them difficult to interpret and potentially unsuitable for diagnostic purposes.  In the interests of the patient, it is advisable that they be transported to the laboratory for processing as soon as is possible to minimise autolysis and promote accurate and timely reporting.To facillitate this, specimens must arrive in the laboratory correctly labelled and packaged and accompanied by an appropriate request form completed with the minimum data set and all relevant patient and clinical details.

Ensure high risk samples are clearly labelled with bio-hazard warning stickers.

SPUTUM CYTOLOGY

Early morning deep cough specimens resulting from overnight accumulation of secretions yield the best diagnostic results.  A single specimen taken on each of three consecutive days should be sent to the laboratory for analysis as soon as it is collected to maximise diagnostic accuracy.  The patient must be carefully instructed not to spit without a deep cough as saliva is of no diagnostic value. The specimen sent is randomly sampled and 5-10ml is regarded as the minimal optimal volume requirement for this test.

FLUID CYTOLOGY

Examples of these include,  pleural or ascitic effusions, peritoneal washings, breast cyst fluid, hydrocele fluid and ovarian cyst fluid. These should be sent fresh, directly to the laboratory or kept refrigerated until transported.  A maximum of 25 mls of the sample should be delivered to the laboratory in a sterile universal container for processing. Do not send drainage bags as transport and disposal of large quantities of unfixed fluid present health and safety risks.

URINARY TRACT CYTOLOGY

A freshly voided or catheter sample  should be collected into  250ml urine pots and sent directly to the department.  If this is impossible refrigerate and transport at the first available opportunity.  The second full voided specimen of the day is optimal for accurate cytological assessment.  Avoid sending the first specimen of the day i.e. an early morning urine, as this has the disadvantage of marked cellular degeneration.  Urine bottles are available from the Cytology department. Please indicate if it is a catheter sample.

BRUSH CYTOLOGY

Examples of these include , gastric, rectal, oesophageal, and bronchial brushings.

Using clean slides, clearly label the frosted  end in pencil, with patient name and PID as a minimum. Spread sample by rolling the brush along the slide. Preparations must be fixed immediately with an alcohol based fixative to preserve the material. Immediate fixation is essential to promote and enhance staining and subsequent accuracy of reporting. 

Brushes used for liquid based cytology preparation must be thoroughly rinsed in  10 ml of CytoLyt a preservative used in Liquid Based Cytology (LBC) as soon after collection as possible.  Any delay in this process may compromise both the quality and quantity of diagnostic material shed from the sampler into the vial and result in potentially suboptimal preparations upon which the diagnosis may be based.

Place slides in a slide carrier (ensure they are separated)  for transportation

FINE NEEDLE ASPIRATION  CYTOLOGY (FNAC)

Examples of these include aspirates from, breast, lymph node, thyroid, and salivary gland .Slides prepared in the clinic for FNAC may either be air-dried and/or alcohol fixed and will be stained in the laboratory accordingly. 

Using clean slides, clearly label the frosted end in pencil with the Patient's name and PID as a minimum. Label slides also with the fixation used ie: wet or dry

It is imperative that specimens are spread thinly and  either wet fixed and or dry fixed immediately , to promote optimal staining and therefore accuracy of reporting.

Wet preparations must be fixed using an alcohol based fixative and dry preparations waved in the air to promote drying.

Residual material from the needle may be rinsed into  10 ml of CytoLyt and transported to the laboratory to be processed for LBC.

Place slides in a slide carrier  (ensure they are separate) for transportation.

Endobronchial Ultrasound Guided Trans-bronchial Needle Aspirate Samples (EBUS)

These samples are processed as for  FNAC.  The needle is washed out in 10 ml CytoLyt solution, sent to the laboratory and processed as for LBC.

CEREBROSPINAL FLUID

These specimens are particularly delicate and require immediate preparation to prevent cellular degeneration.  They must be sent directly to the laboratory in a sterile universal container clearly labelled with the patient's name and PID.  If sending after 16:00 please inform the laboratory at the earliest opportunity prior to despatch to ensure staff availability for timely preparation. Sample volume obtained from the patient for this test is usually less than 1ml hence all material sent is usually processed.

BRONCHOALVEOLAR LAVAGE CYTOLOGY (BAL)

(for differential cell count)

These specimens must be in as near a natural state as possible for accuracy of reporting.  They must be collected into a sterile, labelled universal container and packed on ice and transported immediately to the laboratory for preparation to prevent cellular degeneration.  Sample volume obtained from the patient for this test is variable however 30 ml is the expected average.  Receipt of BAL samples during the early part of the working day is encouraged to enable processing and preparation of the slides.  If the sample is expected to be received after 16:00 pm the department must be telephoned.

Bronchoalveolar Lavage samples for Cytology must be sent to the laboratory on ice - this is essential to ensure minimal cell degeneration. They should be packed in ice, sealed and delivered to Pathology by a porter. Please inform the lab of their expected arrival time, to ensure staff are available to process the sample.

SYNOVIAL FLUID CYTOLOGY (for crystals)

These specimens must be sent in a sterile white capped universal container. Please ensure the request form is clearly labelled "for crystals". 5ml is an optimal  sample  volume for processing and reporting.

Miscellaneous  Non-Gynae Samples

Please contact the Cytology laboratory for advice regarding unususal samples.

Factors affecting performance

Please ensure that samples arrive in the laboratory as soon as possible after collection as unfixed cells degenerate quickly 

Please ensure that unfixed material spread onto glass slides following FNA procedures are air dried rapidly to facillitate staining

Please ensure that cytology brush specimens spread on glass slides are fixed immediately with spray fixative to prevent cellular autolysis

Please ensure that material left over from cytology brush samples are immersed in fixative solution (PreservCyt) immediately following procedures.

Please inform the laboratory of any urgent samples to facillitate reporting times

Transport of Cytology Specimens

on .

Bronchoalveolar Lavage samples for Cytology must be sent to the laboratory on ice - this is essential to ensure minimal cell degeneration. They should be packed in ice, sealed and delivered to Pathology by a porter. Please inform the lab of their expected arrival time, to ensure staff are available to process the sample.

Clinical advice and interpretation (Cytology)

on .

FOR CLINICAL ADVICE CONTACT Dr Bruce Tanchel (Lead Cytopathologist) 0121 4241192 Mon-Friday 9am-5pm 

HPV Testing of LBC Samples

Birmingham Heartlands Cytology Department will commence roll-out of HPV (Human Papiloma Virus) testing as part of the NHS Cervical Screening Programme from Monday 1st October 2012.

All cervical screening sample takers should have already received HPV training packs via their PCT Cervical Screening Coordinators.

Further information about the cervical screening programme and HPV testing can be found on the NHS Cervical Screening Programme Website please click the link below:

More information about HPV and cervical screening

HPV triage and test of cure protocol flowchart

Reporting times

In line with NHS Cervical Screening Programme (NHSCSP) Guidelines - 98% of cervical screening results should be available within 14 days. 

Further examination on LBC samples is possible but will only be carried out following discussion with a Consultant Pathologist. Samples are kept for a minimum of 48 hours after the final report has been issued.  Stained slides are kept for 10 years.

Further information on Cytology 14 day Turnaround can be found at: http://www.cancerscreening.nhs.uk/cervical/14-tat.html

 

NHSCSP GUIDELINES

A: GUIDELINES FOR ACTION ON CYTOLOGY (without HPV testing)

               

REPORT

ACTION

Inadequate

Repeat in 3 months

Third consecutive inadequate

Refer to colposcopy

Negative

Routine Recall

Borderline nuclear changes (first)

Repeat in six months

Second BNC

Repeat in six months

Third BNC

Refer to colposcopy

Borderline ?high grade

Refer to Colposcopy

Mild dyskaryosis

Refer to colposcopy

Combination of BNC (x1) and mild dysk (x1)

Refer to colposcopy

Moderate and severe dyskaryosis

Refer to colposcopy

Severe dyskaryosis?invasive

Urgent 2 week referral to colposcopy

 

 

 

B: GUIDELINES FOR ACTION ON CYTOLOGY - GLANDULAR ABNORMALITIES (without HPV testing)

REPORT

ACTION

Glandular Borderline

Refer to Colposcopy

?Glandular neoplasia - Endocervical

Urgent 2 week referral to colposcopy

?Glandular neoplasia – Non cervical

Urgent 2 week referral to a Gynaecologist * NB Not part of laboratory “direct referral” process

 

C: GUIDELINES FOR ACTION ON CYTOLOGY FOLLOWING HPV TRIAGE

REPORT

ACTION

BNC HR-HPV detected

Refer to colposcopy

BNC HR-HPV not detected

Routine recall

BNC HPV test unavailable/unreliable

Repeat in 6 months (with HPV test)

BNC in glandular cells HR-HPV detected

Refer to colposcopy

BNC in glandular cells HR-HPV not detected

Routine recall

BNC in glandular cells HPV test unavailable/unreliable

Refer to colposcopy (code as 9S)

Mild dyskaryoisis HR-HPV detected

Refer to colposcopy

Mild dyskaryosis HR-HPV not detected

Routine recall

Mild dyskaryosis HR-HPV test unavailable/unreliable

Refer to colposcopy

BNC ?high grade HR –HPV detected

Refer to colposcopy

BNC ?high grade HR-HPV not detected

Routine recall

BNC ?high grade HR-HPV unavailable/unreliable

Refer to colposcopy (code as 8S)

 

 

 

 

 

D: GUIDELINES FOR CYTOLOGY FOLLOW UP (without HPV testing)

PREVIOUS SMEAR HISTORY

FOLLOW UP

 

BNC

Three negative smears, one at 6 months and two annual smears. If all negative return to routine screening.

 

Mild dyskaryosis

Three negative smears, one at 6 months and two annual smears. If all negative return to routine screening.

 

Moderate and severe dysk and ?glandular neoplasia and severe ?invasive

Ten negative smears, one at 6 months and nine annual smears. If all negative return to routine screening.

 

         E: GUIDELINES FOR CYTOLOGY FOLLOW-UP - UNTREATED CIN (following HPV testing)

REPORT

FOLLOW UP

 

Negative – no repeat HPV test required

 

Follow normal NHSCSP protocols

 

BNC HR-HPV detected

 

Refer back to colposcopy

 

BNC HR-HPV not detected

 

Return to routine recall

Any grade of dyskaryosis – no repeat HPV test required.

 

 

Refer back to colposcopy

                                                                                             

F: GUIDELINES FOR FOLLOW-UP POST TREATMENT OF CIN (without HPV testing)

HISTOLOGICAL GRADING

FOLLOW UP

 

CIN 1

Repeat cytology in 6 months. If negative annual cytology follow up for two years. Unless high-grade on referral cytology when follow-up protocol will be decided at Colposcopy MDT.

 

CIN 2 and 3

 

Repeat cytology in 6 months. If negative annual smears for 9 years in Primary Care.

CGIN

Repeat at 6 monthly intervals for 5 years in Colposcopy with cervix broom and endocervical brush (1 vial). If all negative return to Primary Care for 5yr annual cytology follow up.

Cervical cancer

Follow up as per MDT recommendation

 

G: GUIDELINES FOR CYTOLOGY FOLLOW-UP POST TREATMENT OF CIN (with HPV testing)

TEST OF CURE

 

HISTOLOGICAL GRADING

FOLLOW UP

 

CIN 1, CIN 2 and CIN 3

 

If follow up cytology is negative , borderline or mild dyskaryoisis and the HR-HPV test of cure is negative – Three yearly recall

CIN1,CIN2 and CIN3

 

If follow up cytology is negative, borderline or mild dyskaryosis and the HR-HPV test of cure is positive. Refer back to Colposcopy

CGIN- No HPV Test of Cure required

Cytology at 6 monthly intervals for 5 years in Colposcopy with cervex broom and endocervical brush (1 vial). If all negative return to Primary Care for 5 year annual cytology follow up.

Cervical cancer- no HPV Test of Cure required

 

Follow up as per MDT recommendation

 

NB. Any high grade dyskaryosis reported during a non-routine follow-up period requires referral back to colposcopy.

Three consecutive inadequate smears must be referred to colposcopy.

H: GUIDELINES FOR FOLLOW-UP POST HYSTERECTOMY WITH

     PREVIOUS ABNORMAL CYTOLOGY – CERVIX REMOVED

HISTOLOGICAL GRADING

FOLLOW UP

 

No CIN/CGIN or cervical cancer detected

 

x1 follow up vault cytology @ 6 months post treatment

 

 

CIN/CGIN or cervical cancer detected. Excision complete

 

x2 follow up vault cytology @ 6 and 18 months post treatment

 

 

CIN/CGIN or cervical cancer detected. Excision incomplete.

 

Follow up vault cytology @ 6 months and then annual follow up as per NHSCSP guidelines

 

 

NB: Vaginal vault samples are not part of the NHS Cervical Screening Programme. Women requiring vaginal vault cytology follow up should remain in the colposcopy clinic for follow up.

Vaginal vault samples taken following hysterectomy for benign conditions or non-cervical cancers are inappropriate and will be rejected. These women should be ceased from the cervical screening programme.

 

I: GUIDELINES FOR FOLLOW-UP POST SUB-TOTAL HYSTERECTOMY WITH PREVIOUS ABNORMAL CYTOLOGY – CERVIX NOT REMOVED (without HPV testing)

 

HISTOLOGICAL GRADING

FOLLOW UP

 

CIN 1

Repeat cytology in 6 months. If negative annual cytology follow up for two years. (Unless high-grade on referral cytology when follow-up protocol will be decided at Colposcopy MDT).

 

CIN 2 and 3

+/- complete excision

+/- gland involvement

 

Repeat cytology in 6 months. If negative annual cytology follow up for 9 years.

 

No abnormality detected – biopsy specimen

 

Refer to box D above or follow MDT decision

Cytopathology Services

on .

Cytopathology Contacts

  • Dr B Tanchel (Lead Cytopathologist)   0121 424 1192
  • Angela Brown (Advanced Practitioner) 0121 424 1191
  • Karen Tomlinson (Hospital based cervical screening co-ordinator/BMS3)  0121 424 1191
  • Jackie Parrish (BMS3)  0121 424 1191 

The Cytology Department is located within Cellular Pathology on the first floor of Laboratory Medicine

Patient Information

on .

No specific patient information data is produced by the laboratory.

National Health Service Cervical and Breast Screening Programme information and guidance information may be found at www.cancerscreening.nhs.uk

Information on liquid based cytology (LBC) can be obtained at www.hologic.com

Reporting times

98% of Cervical Screening results should be available within 2 weeks. Please do not telephone the laboratory for results as we are unable to give results directly to patients. Results should be obtained from your GP or whoever took the sample.